Document is current
Any future updates will be listed below
-
Authors
Mkhikian, Haik https://orcid.org/0000-0003-4560-306X
Hayama, Ken L.
Khachikyan, Khachik
Li, Carey
Zhou, Raymond W.
Pawling, Judy
Klaus, Suzi
Tran, Phuong Q. N.
Ly, Kim M.
Gong, Andrew D.
Saryan, Hayk
Hai, Jasper L.
Grigoryan, David
Lee, Philip L.
Newton, Barbara L.
Raffatellu, Manuela https://orcid.org/0000-0001-6487-4215
Dennis, James W. https://orcid.org/0000-0002-0295-5877
Demetriou, Michael https://orcid.org/0000-0001-8547-5774
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI126277, R01AI114625, R01AI108917, R01AI144403)
U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (R01AT007452)
- License Information
-
More Information
Article History
Received: 24 March 2021
Accepted: 2 February 2022
First Online: 18 March 2022
Competing interests
: J.D. and M.D. are named as inventors on a patent application that describes GlcNAc as a biomarker for multiple sclerosis. J.D. and M.D. are named as inventors on a patent for use of GlcNAc in multiple sclerosis. The remaining authors declare no competing interests.
